The anorectic peptide GLP-1, which is primarily released from enteroendocrine L cells in response to meals, functions as a satiety signal 13
Subtle differences with respect to interactions with the ECLsspecifically, the TM 6-ECL3-TM7/TM1have led to biased agonism (i.e., selective agonism of the cAMP signaling pathway)
Once the water is added, gently swirl the vial
Of the 13 GLP-1 medications listed by the FDA, only three, Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound, (tirzepatide), are officially listed as approved for weight loss
These provide sweetness alongside beneficial nutrients and fibre, which help moderate blood sugar responses